Established and emerging therapies for the treatment of viral hepatitis

被引：8
作者：
Forton, Daniel
Karayiannis, Peter
机构：
[1] Imperial Coll London, Fac Med, Dept Med A, Hepatol Sect, London W2 1NY, England
[2] Imperial Coll, Dept Med A, London, England
来源：
DIGESTIVE DISEASES | 2006年 / 24卷 / 1-2期
关键词：
hepatitis B virus; hepatitis C virus; treatment; interferon; pegylated interferon; antivirals nucleos(t)ide analogues; lamivudine; adefovir dipivoxil; ribavirin; resistance;
D O I：
10.1159/000090319
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Patients who are chronically infected with either hepatitis B or C viruses run the risk of developing cirrhosis and hepatocellular carcinoma in later life. Antiviral treatment offers the only means of interrupting this progression. To date, recombinant interferon alpha and the nucleos(t)ide analogues lamivudine and adefovir dipivoxil are the only licensed drugs for the treatment of chronic hepatitis B, whilst recombinant or pegylated interferons in combination with ribavirin are the ones used for chronic hepatitis C virus infections. The efficacy of these treatments, reasons for treatment failure, drug resistance and future options are discussed in the present review. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码：160 / 173
页数：14
相关论文
共 139 条
[1]   Epoetin alfa maintains ribavirin dose in HCV-infected patients: A prospective, double-blind, randomized controlled study [J].
Afdhal, NH ;
Dieterich, DT ;
Pockros, PJ ;
Schiff, ER ;
Shiffman, ML ;
Sulkowski, MS ;
Wright, T ;
Younossi, Z ;
Goon, BL ;
Tang, KL ;
Bowers, PJ .
GASTROENTEROLOGY, 2004, 126 (05) :1302-1311
[2]   HEPATITIS-C VIREMIA AND LIVER-DISEASE IN SYMPTOM-FREE INDIVIDUALS WITH ANTI-HCV [J].
ALBERTI, A ;
MORSICA, G ;
CHEMELLO, L ;
CAVALLETTO, D ;
NOVENTA, F ;
PONTISSO, P ;
RUOL, A .
LANCET, 1992, 340 (8821) :697-698
[3]   Identification and characterization of mutations in hepatitis B virus resistant to lamivudine [J].
Allen, MI ;
Deslauriers, M ;
Andrews, CW ;
Tipples, GA ;
Walters, KA ;
Tyrrell, DLJ ;
Brown, N ;
Condreay, LD .
HEPATOLOGY, 1998, 27 (06) :1670-1677
[4]   Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome [J].
Alter, HJ ;
Seeff, LB .
SEMINARS IN LIVER DISEASE, 2000, 20 (01) :17-35
[5]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[6]   Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase [J].
Angus, P ;
Vaughan, R ;
Xiong, S ;
Yang, HL ;
Delaney, W ;
Gibbs, C ;
Brosgart, C ;
Colledge, D ;
Edwards, R ;
Ayres, A ;
Bartholomeusz, A ;
Locarnini, S .
GASTROENTEROLOGY, 2003, 125 (02) :292-297
[7]   Ascending multiple-dose pharmacokinetics of viramidine, a prodrug of ribavirin, in adult subjects with compensated hepatitis C infection [J].
Aora, S ;
Xu, C ;
Teng, A ;
Peterson, J ;
Yeh, LT ;
Gish, R ;
Lou, D ;
Rossi, S ;
Lin, C .
JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (03) :275-285
[8]   Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation [J].
Bain, VG ;
Kneteman, NM ;
Ma, MM ;
Gutfreund, K ;
Shapiro, JA ;
Fischer, K ;
Tipples, G ;
Lee, H ;
Jewell, LD ;
Tyrrell, DL .
TRANSPLANTATION, 1996, 62 (10) :1456-1462
[9]   Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial [J].
Barbaro, G ;
Zechini, F ;
Pellicelli, AM ;
Francavilla, R ;
Scotto, G ;
Bacca, D ;
Bruno, M ;
Babudieri, S ;
Annese, M ;
Matarazzo, F ;
Di Stefano, G ;
Barbarini, G .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :406-411
[10]   Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].
Bartholomew, MM ;
Jansen, RW ;
Jeffers, LJ ;
Reddy, KR ;
Johnson, LC ;
Bunzendahl, H ;
Condreay, LD ;
Tzakis, AG ;
Schiff, ER ;
Brown, NA .
LANCET, 1997, 349 (9044) :20-22
12345678910